Ipafricept: Interim Ph Ib data

Interim data from 18 evaluable patients in an open-label, dose-escalation, U.S. Phase Ib trial showed that IV ipafricept on

Read the full 194 word article

How to gain access

Continue reading with a
two-week free trial.